Latest On Sartorius Stedim Biotech S.A (SDMHF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-04-02 05:58 EST | Dividend | A dividend of $0.69 has been announced on Feb 9, 2024. It will be paid Apr 4, 2024 with an ex-dividend date of Apr 2, 2024. | Neutral |  |
| 2023-04-03 13:37 EST | News | Sartorius: Polyplus Acquisition Raises Concerns | N/A | |
| 2023-03-30 06:08 EST | Dividend | A dividend of $1.44 has been announced on Feb 8, 2023. It will be paid Apr 3, 2023 with an ex-dividend date of Mar 30, 2023. | Neutral | |
| 2023-01-27 03:24 EST | News | Sartorius Stedim Biotech S.A. (SDMHF) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-01-26 15:01 EST | News | Sartorius Stedim Biotech S.A. GAAP EPS of €8.64, revenue of €3.49M | N/A | |
| 2022-10-19 02:47 EST | News | Sartorius Stedim Biotech 9M GAAP EPS of €6.58, revenue of €2.6B; updates FY22 guidance | N/A | |
| 2022-07-21 05:35 EST | News | Sartorius Stedim Biotech S.A. GAAP EPS of €4.40, revenue of €1.72B | N/A | |
| 2022-05-09 21:12 EST | News | Sartorius AG: Buy The French Subsidiary Instead | N/A | |
| 2022-04-21 11:58 EST | News | Sartorius Stedim Biotech S.A. Non-GAAP EPS of €2.21, revenue of €862.5M | N/A | |
| 2022-03-31 06:00 EST | Dividend | A dividend of $1.26 has been announced on Feb 16, 2022. It will be paid Apr 4, 2022 with an ex-dividend date of Mar 31, 2022. | Neutral | |
| 2022-03-28 05:59 EST | Dividend | A dividend of $1.26 has been announced on Feb 16, 2022. It will be paid Mar 30, 2022 with an ex-dividend date of Mar 28, 2022. | Neutral | |
| 2022-02-08 09:45 EST | News | Sartorius Stedim acquires Novasep's chromatography division; boosts sales guidance | N/A | |
| 2022-02-01 02:08 EST | News | Sartorius Stedim Biotech S.A. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-01-27 07:38 EST | News | Sartorius Stedim Biotech Non-GAAP EPS of €7.46, revenue of €2.89B | N/A | |
| 2021-10-20 19:54 EST | News | Sartorius Stedim Biotech reports Q3 results | N/A | |
| 2021-08-28 15:09 EST | News | Sartorius Stedim Biotech: Backend Biopharmaceutical Development And Production Powerhouse | N/A | |
| 2021-07-22 12:38 EST | News | Sartorius Stedim Biotech S.A. reports H1 results | N/A | |
| 2021-07-22 12:37 EST | News | Sartorius Stedim Biotech S.A. (SDMHF) CEO Joachim Kreuzburg on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 12:37 EST | News | Sartorius Stedim Biotech S.A. 2021 Q1 - Results - Earnings Call Presentation | N/A | |
| 2021-03-29 06:01 EST | Dividend | A dividend of $0.68 has been announced on Feb 12, 2021. It will be paid Mar 31, 2021 with an ex-dividend date of Mar 29, 2021. | Neutral | |
| 2021-03-18 09:36 EST | News | Sartorius Stedim Biotech raises FY2021 expectation on strong order intake | N/A | |
| 2021-02-21 09:14 EST | Financials | Company financials have been released. | Neutral | |
| 2021-01-06 13:50 EST | News | Sartorius Stedim Biotech to buy Novasep's chromatography process equipment division | N/A | |
| 2020-11-26 22:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 05:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-20 09:46 EST | News | Sartorius Stedim Biotech S.A. reports 9M results, raised FY2020 outlook | N/A | |
| 2020-09-26 15:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 18:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 06:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-22 08:29 EST | News | Sartorius Stedim Biotech S.A. 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-07-21 05:12 EST | News | Sartorius Stedim Biotech S.A. reports 1H results | N/A | |
| 2020-07-09 10:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-29 06:00 EST | Dividend | A dividend of $0.34 has been announced on Feb 14, 2020. It will be paid Jul 1, 2020 with an ex-dividend date of Jun 29, 2020. | Neutral | |
| 2020-06-19 14:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:47 EST | Financials | Company financials have been released. | Neutral | |
About Sartorius Stedim Biotech S.A (SDMHF):
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
General
- Name Sartorius Stedim Biotech S.A
- Symbol SDMHF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 7,566
- Last Split Factor6:1
- Last Split Date2016-05-06
- Fiscal Year EndDecember
- Web URLhttp://www.sartorius.com
View More
Valuation
- Trailing PE 169.22
- Forward PE 60.24
- Price/Sales (Trailing 12 Mt.) 16.02
- Price/Book (Most Recent Quarter) 20.96
- Enterprise Value Revenue 19.73
- Enterprise Value EBITDA 63.7
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 19%
- Return on Assets 13%
- Return on Equity 27%
- Earnings Per Share $2.34
- Revenue Per Share $0
- Gross Profit 1 billion
- Quarterly Earnings Growth 45.8%
View More
ESG Rating
Highlights
- Market Capitalization 37.08 billion
- PEG Ratio 3.94
- Book Value Per Share $12.32
View More
Share Statistics
- Shares Outstanding 92.18 million
- Shares Float 24.14 million
- % Held by Insiders 7430%
- % Held by Institutions 11.3%
View More
Technicals
- Beta 0.03
- 52 Week High $499
- 52 Week Low $174.44
- 50 Day Moving Average 438.54
- 200 Day Moving Average 380.12
View More
Dividends
- Forward Annual Dividend Rate $0.38
- Forward Annual Dividend Yield 0.1%
- Payout Ratio 21%
- Dividend Date N/A
- ExDividend Date 2020-06-29
- Dividend Per Share $0.54
- Dividend Yield 0%
View More
Sartorius Stedim Biotech S.A (SDMHF) Dividend Calendar:
Sartorius Stedim Biotech S.A pays out 21% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Sartorius Stedim Biotech S.A (SDMHF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $N/A | $1.48 | ||
| 2020-09-30 | 2020-12-31 | $N/A | $1.52 | $0.95 | 59.59% |
| 2020-06-30 | 2020-09-30 | $N/A | $1.29 | $0.90 | 43.32% |
| 2020-03-31 | 2020-06-30 | $N/A | $0.82 | $0.76 | 7.93% |
| 2019-12-31 | 2020-03-31 | $363.87 million | $0.89 | $0.70 | 27.53% |
| 2019-09-30 | 2019-12-31 | $367.4 million | $0.66 | $0.69 | -4.04% |
| 2019-06-30 | 2019-09-30 | $366.4 million | $0.69 | $0.67 | 2.49% |
| 2019-03-31 | 2019-06-30 | $342.9 million | $0.80 | $0.61 | 30.49% |
| 2018-12-31 | 2019-03-31 | $316.05 million | $0.68 | $0.59 | 15.97% |
| 2018-09-30 | 2018-12-31 | $310.4 million | $0.85 | $0.59 | 43.41% |
| 2018-06-30 | 2018-09-30 | $304.6 million | $0.63 | $0.54 | 16.09% |
| 2018-03-31 | 2018-06-30 | $281.1 million | $0.63 | $0.53 | 18.96% |
| 2017-12-31 | 2018-03-31 | $274.53 million | $0.54 | $0.52 | 4.23% |
| 2017-09-30 | 2017-12-31 | $259.7 million | $0.57 | $0.49 | 16.94% |
| 2017-06-30 | 2017-09-30 | $277.9 million | $0.48 | $0.51 | -4.98% |
| 2017-03-31 | 2017-06-30 | $268.8 million | $0.48 | ||
| 2016-12-31 | 2017-03-31 | $266.51 million | $0.46 | $0.41 | 11.9% |
| 2016-09-30 | 2016-12-31 | $0.39 | $0.54 | -28.28% | |
| 2016-06-30 | 2016-09-30 | $0.53 | |||
| 2016-03-31 | 2016-06-30 | $0.48 | |||
| 2015-12-31 | 2016-03-31 | $0.45 | |||
| 2015-09-30 | 2015-12-31 | $0.29 | |||
| 2015-06-30 | 2015-09-30 | $0.50 | |||
| 2015-03-31 | 2015-06-30 | $0.39 | |||
| 2014-12-31 | 2015-03-31 | $0.22 | |||
| 2014-09-30 | 2014-12-31 | $0.24 | |||
| 2014-06-30 | 2014-09-30 | $0.27 | |||
| 2014-03-31 | 2014-06-30 | $0.29 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.23 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.25 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.22 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.29 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.19 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.20 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.23 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.16 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.20 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.15 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.18 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.15 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.17 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.17 | $0.00 |
Sartorius Stedim Biotech S.A (SDMHF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | 23.42 million |
| Income Before Tax | N/A | N/A | N/A | N/A | 73.21 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 82.56 million |
| Gross Profit | N/A | N/A | N/A | N/A | 190.85 million |
| Ebit | N/A | N/A | N/A | N/A | 97.04 million |
| Operating Income | N/A | N/A | N/A | N/A | 97.04 million |
| Income Tax Expense | 29.11 million | 39.2 million | 27.6 million | 26.5 million | 17.92 million |
| Total Revenue | N/A | N/A | N/A | N/A | 363.87 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | 173.02 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -23.83 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 55.28 million |
| Net Income Applicable to Common Shares | 114.25 million | 101.5 million | 67.5 million | 75.1 million | 55.07 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -40.3 million | N/A | N/A | N/A | N/A |
| Change to Liabilities | N/A | N/A | N/A | N/A | -33.5 million |
| Total Cash Flow from Investing Activities | -40.3 million | -246.7 million | -49.7 million | -82 million | -39.1 million |
| Net Borrowings | 16.7 million | 185.8 million | -20.3 million | -8.94 million | -34.2 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | -11.76 million | -35.8 million |
| Change to Operating Activities | 49.1 million | 44.9 million | 10.7 million | -18.37 million | 78.3 million |
| Change in Cash | 76.3 million | N/A | N/A | -7.43 million | 9.5 million |
| Total Cash from Operating Activities | 132 million | 79.9 million | 115.4 million | 86.23 million | 83.9 million |
| Depreciation | 25.7 million | N/A | N/A | 13.97 million | 17.9 million |
| Other Cash Flow from Investing Activities | -9.5 million | -3.6 million | -24.5 million | -1000 | 63.8 million |
| Change to Inventory | -40.4 million | N/A | N/A | -9.91 million | -22.6 million |
| Change to Account Receivables | N/A | N/A | N/A | 30.54 million | -26.7 million |
| Other Cash Flow from Financing Activities | -800000 | -2.1 million | -1.9 million | -2.78 million | -1.6 million |
| Change to Net Income | 21.9 million | 6.7 million | 10.2 million | 5.86 million | 11.9 million |
| Capital Expenditures | 26.8 million | N/A | N/A | 37.57 million | 98.4 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 983.9 million | N/A | N/A | 642.79 million |
| Total Stockholder Equity | N/A | 1.35 billion | N/A | N/A | 1.16 billion |
| Other Current Liabilities | 309.22 million | 66.1 million | N/A | N/A | 216.08 million |
| Total Assets | N/A | 2.36 billion | N/A | N/A | 1.82 billion |
| Common Stock | 18.44 million | 18.4 million | 18.4 million | 18.4 million | 18.44 million |
| Other Current Assets | 69.34 million | 39 million | N/A | N/A | 27.9 million |
| Retained Earnings | 1.23 billion | 1.1 billion | 1.01 billion | 976.9 million | 899.46 million |
| Other Liabilities | 455.78 million | 145.7 million | 144.2 million | 135 million | 134.75 million |
| Other Assets | 254.7 million | 22.1 million | 20.6 million | 21.6 million | 181.59 million |
| Cash | N/A | 165.9 million | N/A | N/A | 27.64 million |
| Total Current Liabilities | 567.69 million | 536.7 million | N/A | N/A | 427.35 million |
| Other Stockholder Equity | 210.42 million | 231.5 million | 231.2 million | 231.5 million | 240.9 million |
| Property, Plant & Equipment | 518.28 million | 566.4 million | 561.7 million | 549.6 million | 466.75 million |
| Total Current Assets | 875.22 million | 961.2 million | N/A | N/A | 633.8 million |
| Long Term Investments | N/A | N/A | N/A | N/A | 15.08 million |
| Net Tangible Assets | 52.4 million | 549.4 million | 448.3 million | 621.7 million | 635.59 million |
| Short Term Investments | N/A | 65.5 million | N/A | N/A | 7.91 million |
| Long Term Debt | N/A | 255.4 million | N/A | N/A | 40 million |
| Inventory | 472.31 million | 437.5 million | N/A | N/A | 328.16 million |
| Accounts Payable | 174.73 million | 239 million | N/A | N/A | 116 million |
Sartorius Stedim Biotech S.A (SDMHF) Chart:
Sartorius Stedim Biotech S.A (SDMHF) News:
Below you will find a list of latest news for Sartorius Stedim Biotech S.A (SDMHF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Sartorius Stedim Biotech S.A (SDMHF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Sartorius Stedim Biotech S.A (SDMHF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|